HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Clinical trial NCT06014190 · RECRUITING

Trial details

NCT number: NCT06014190
Sponsor: Hansoh BioMedical R&D Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer Endometrial Cancer

Start date: 2023-12-18
Primary completion: 2025-12-31
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.